It is a pharma private limited company based in Tehsil Roorkee, Uttarakhand, India, established in 2019.
2019 | Tehsil Roorkee, Uttarakhand, India | ActiveKancare Pharmaceuticals Private Limited, a active private limited company, was established on 15 February 2019 in Tehsil Roorkee, Uttarakhand, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299UR2019PTC009529. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 14 professional, Its leadership includes Preeti Paliwal (Director), Mayank Kumar (Director), Shobha Tyagi (Director). Past directors included Mohd Tahseen. It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Khasra No. 396 Vill.Nanheda Anantpur,Pargana Bhagwanpur, Tehsil Roorkee, Uttarakhand, 247667.
U24299UR2019PTC009529
009529
15 February 2019
₹5.00 M
₹1.00 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Kancare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preeti Paliwal | Director | 15 Feb 2019 | Current |
| Mayank Kumar | Director | 15 Feb 2019 | Current |
| Shobha Tyagi | Director | 15 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kancare Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 11923.18% increase in profit. The company's net worth Soared by an impressive increase of 1936.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Kancare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2020 | Others | ₹8.00 M | Open |
Explore comprehensive loan charge details -
Kancare Pharmaceuticals has a workforce of 14 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kancare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kancare Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kancare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Kancare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Uttarakhand. was completed.
The activity A charge with Others amounted to Rs. 8.00 M with Charge ID 100351114 was registered on 03 Jul 2020. was completed.
Preeti Paliwal was appointed as a Director was appointed as a Director on 15 Feb 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
Progress on Mayank Kumar was appointed as a Director was appointed as a Director on 15 Feb 2019 & has been associated with this company since 6 years 10 months . was documented.
The activity Shobha Tyagi was appointed as a Director was appointed as a Director on 15 Feb 2019 & has been associated with this company since 6 years 10 months . was completed.
The CIN of Kancare Pharmaceuticals Private Limited is U24299UR2019PTC009529.
Kancare Pharmaceuticals Private Limited is headquartered at Khasra No. 396 Vill.Nanheda Anantpur,Pargana Bhagwanpur, Tehsil Roorkee, Uttarakhand, 247667.
Kancare Pharmaceuticals Private Limited was incorporated on 15 February 2019.
The current directors of Kancare Pharmaceuticals Private Limited are
The primary industry of Kancare Pharmaceuticals Private Limited is Pharma.
Kancare Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kancare Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kancare Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX